sp2-Iminosugars targeting human lysosomal β-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease
The late-onset form of Tay-Sachs disease displays when the activity levels of human β-hexosaminidase A (HexA) fall below 10% of normal, due to mutations that destabilise the native folded form of the enzyme and impair its trafficking to the lysosome. Competitive inhibitors of HexA can rescue disease...
প্রধান লেখক: | , , , , , , , , |
---|---|
বিন্যাস: | প্রবন্ধ |
ভাষা: | English |
প্রকাশিত: |
Taylor & Francis Group
2022-12-01
|
মালা: | Journal of Enzyme Inhibition and Medicinal Chemistry |
বিষয়গুলি: | |
অনলাইন ব্যবহার করুন: | https://www.tandfonline.com/doi/10.1080/14756366.2022.2073444 |